chloramphenicol has been researched along with chlorpropamide in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (25.00) | 29.6817 |
2010's | 6 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jaeger, W | 1 |
de Vries, A; Mintz, U; Pinkhas, J; Shaklai, M | 1 |
Christensen, LK; Hansen, JM | 1 |
Fabre, J; Petitpierre, B | 1 |
Hansten, PD | 1 |
Fabre, J; Herrera, A; Perrin, L; Petitpierre, B; Rudhardt, M | 1 |
Fabre, J; Perrin, L; Petitpierre, B; Rudhardt, M | 2 |
Leopold, IH | 1 |
Hynes, HE; Recker, RR | 1 |
THIJSSE, GJ; van der LINDEN, A | 1 |
ERSLEV, AJ | 1 |
2 review(s) available for chloramphenicol and chlorpropamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug interactions with oral sulphonylurea hypoglycaemic drugs.
Topics: Allopurinol; Analgesics; Anticoagulants; Chloramphenicol; Chlorpropamide; Disulfiram; Drug Interactions; Ethanol; Glyburide; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kinetics; Monoamine Oxidase Inhibitors; Novobiocin; Phenylbutazone; Phenytoin; Probenecid; Propranolol; Rifampin; Sulfonamides; Sulfonylurea Compounds; Tolbutamide | 1977 |
22 other study(ies) available for chloramphenicol and chlorpropamide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Acquired colour-vision-deficiencies caused by side-effects of pharmacotherapy (author's transl)].
Topics: Antipsychotic Agents; Chloramphenicol; Chloroquine; Chlorpropamide; Color Vision Defects; Contraceptives, Oral; Digitoxin; Ethambutol; Humans; Indomethacin; Monoamine Oxidase Inhibitors; Optic Neuritis; Phenothiazines; Retinal Diseases; Sparsomycin | 1977 |
Drug-induced agranulocytosis. A survey of twenty-three episodes.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Aminopyrine; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antithyroid Agents; Chloramphenicol; Chlorpropamide; Dipyrone; Female; Humans; Male; Middle Aged | 1975 |
Chlorpropamide and chloramphenicol.
Topics: Chloramphenicol; Chlorpropamide; Humans; Kidney; Tolbutamide | 1970 |
Chlorpropamide and chloramphenicol.
Topics: Chloramphenicol; Chlorpropamide; Drug Synergism; Humans | 1970 |
Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy.
Topics: Acenocoumarol; Allopurinol; Chloramphenicol; Chlorpropamide; Clofibrate; Glomerular Filtration Rate; Glomerulonephritis; Half-Life; Humans; Kidney; Kidney Diseases; Probenecid; Pyelonephritis | 1972 |
[Behavior of chlorpropamide in nephropathies in the presence of associated drugs].
Topics: Allopurinol; Chloramphenicol; Chlorpropamide; Chromium Isotopes; Humans; Kidney Diseases; Probenecid | 1972 |
[Kinetics of chlorpropamide in renal insufficiency. Effect of associated therapeutics].
Topics: Chloramphenicol; Chlorpropamide; Diabetes Complications; Diabetes Mellitus; Drug Interactions; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic | 1971 |
Ocular complications of drugs. Visual changes.
Topics: Adrenal Cortex Hormones; Cardiac Glycosides; Chloramphenicol; Chlorpropamide; Drug-Related Side Effects and Adverse Reactions; Electroretinography; Eye Diseases; Humans; Ophthalmoscopy; Phenothiazines; Quinolines; Vision Disorders; Vision Tests | 1968 |
Pure red blood cell aplasia associated with chlorpropamide therapy. Patient summary and review of the literature.
Topics: Adolescent; Adult; Aminosalicylic Acids; Anemia, Aplastic; Aspirin; Barbiturates; Child; Child, Preschool; Chloramphenicol; Chlorpropamide; Colchicine; Female; Glutethimide; Heparin; Humans; Infant; Isoniazid; Male; Middle Aged; Phenytoin; Riboflavin | 1969 |
Pathways of hydrocarbon dissimilation by a Pseudomonas as revealed by chloramphenicol.
Topics: Chloramphenicol; Chlorpropamide; Humans; Hydrocarbons; Pseudomonas; Pseudomonas aeruginosa | 1963 |
DRUG-INDUCED BLOOD DYSCRASIAS. I. APLASTIC ANEMIA.
Topics: Acetazolamide; Anemia; Anemia, Aplastic; Anticonvulsants; Benzene; Chloramphenicol; Chlorothiazide; Chlorpropamide; Gold; Hematologic Diseases; Hexachlorocyclohexane; Phenylbutazone; Prednisone; Sulfamethoxypyridazine; Sulfisoxazole; Testosterone; Tolbutamide; Toxicology | 1964 |